vimarsana.com
Home
Live Updates
EILEAN THERAPEUTICS APPROVED TO INITIATE FIRST PATIENT TRIAL
EILEAN THERAPEUTICS APPROVED TO INITIATE FIRST PATIENT TRIAL
EILEAN THERAPEUTICS APPROVED TO INITIATE FIRST PATIENT TRIAL WITH BALAMENIB (ZE63-0302), A SELECTIVE BEST-IN-CLASS MENIN INHIBITOR
/PRNewswire/ -- Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule...
Related Keywords
Dover ,
Tasmania ,
Australia ,
Australian ,
Johnc Byrd ,
Amy Burd ,
Expert Systems Inc ,
Prnewswire Eilean Therapeutics ,
Eilean Therapeutics Australia Pty Ltd ,
Human Research Ethics Committee ,
Australian Therapeutics Goods Administration ,
Eilean Therapeutics ,
Eilean Therapeutics Australia Pty ,
Clinical Trial Notification ,
Iain Dukes ,
Chief Executive Officer ,
Eilean Therapeutic ,
Torrey Pines Investment ,